An HIV prevention injection that provides six months of protection per shot has been shown to be highly effective in a pivotal trial largely conducted in South Africa. There are however some concerns as to when the injection will become available and how widely. Thabo Molelekwa and Marcus Low report.
One of the biggest stories in HIV in the last year was that a class of medicines called statins could help reduce cardiovascular disease in people living with the virus. In response, treatment guidelines in the United States were quickly updated, but the picture is more complicated in South Africa. Spotlight’s Elri Voigt explores why the case for widespread use of statins by people living with HIV is less compelling in South Africa than in some other countries.
Dr Moherndran Archary’s research has helped shape South African health policy, most notably the rollout of better HIV treatments for children and babies. Spotlight’s Biénne Huisman chatted to him about the state of HIV treatment for kids and some exciting prospects on the horizon.
Healthcare is an issue that at some point touches everyone in South Africa. It is also an issue that will impact who people vote for on the 29th of May. To help voters understand just what parties are putting on the table when it comes to healthcare, Spotlight pin-pointed seven critical healthcare questions and put them to 10 political parties.
Elri Voigt unpacks the complex effect that HIV has on the kidneys, how HIV and chronic kidney disease has evolved after the roll out of anti-retroviral treatment, and what the situation is now in the country for people living with HIV and chronic kidney disease.
That HIV can develop resistance to the drugs used to treat it is nothing new, but results from recent studies reveal the emergence of resistance in subsets of people living with HIV to dolutegravir – an antiretroviral widely used in South Africa. Top HIV experts spoke to Elri Voigt about the new findings and what it means for people living with HIV in the country.
Despite South Africa’s impressive HIV testing figures, a subset of people started taking antiretroviral therapy far later than is ideal for their health, shows new data from the leading mathematical model of HIV in the country.
Scientists worldwide are sounding the alarm at the return of syphilis, describing the comeback of the easily preventable infection as a huge public health failing – as an effective vaccine remains elusive.
Condom distribution in South Africa has dropped dramatically over the last five years, finds a Spotlight analysis of data recently published in the Health System Trust’s District Health Barometer.
There are serious gaps in psychiatry regarding treatment, prevention and care for children and adolescents in South Africa. Offering solutions, Dr Anusha Lachman tells Spotlight psychiatric services should be offered in ways that are Afro-centric and culturally sensitive.
Nthusang Lefafa looks at the latest Ritshidze report for key populations and speaks to some public healthcare experts about possible solutions to challenges facing those marginalised groups who carry a high burden of the HIV pandemic.
Over the last four years South Africa has taken large strides in making HIV prevention pills available at public sector clinics, but uptake has not been as good as some may have hoped. Thabo Molelekwa asks several experts why this might be.